Interestingly, Zou and collaborators reported that actual recurrence (i.e., tumour enlargement or recurrence irrespective of prolactin levels) is rare after drug suspension, suggesting that isolated relapsing hyperprolactinemia may not need treatment; further studies are needed to better address this topic [29]. The gene discussed is PRL; the disease is neoplasm.